Crossmark

The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2843-9

Published Online: 2018-08-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmadi, Jamshid

Jahromi, Mina Sefidfard

Ehsaei, Zahra
Funding

Funding for this research was provided by:

Shiraz University of Medical Sciences (IR.SUMS.REC.1395.102,)
License Information

Text and Data Mining valid from 2018-08-29
More Information

Article History

Received: 5 September 2017

Accepted: 6 August 2018

First Online: 29 August 2018

Authors’ information

: JA: Professor of Psychiatry, Founding Director of Substance Abuse Research Center. MS and ZE: Department of Psychiatry, Shiraz University of Medical Sciences.

: Dr. Hashemi verified ethical approval (, registration date: 2017-01-24). Informed consent has been obtained from all participants.

: The patients have agreed to the publication of data.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below